News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,578 Results
Type
Article (48204)
Company Profile (282)
Press Release (703076)
Multimedia
Podcasts (94)
Webinars (23)
Section
Business (210240)
Career Advice (2129)
Deals (36243)
Drug Delivery (132)
Drug Development (83674)
Employer Resources (177)
FDA (16940)
Job Trends (15326)
News (355932)
Policy (33745)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2750)
Accelerated approval (42)
Adcomms (32)
Allergies (163)
Alliances (51048)
ALS (196)
Alzheimer's disease (1791)
Antibody-drug conjugate (ADC) (374)
Approvals (17248)
Artificial intelligence (607)
Autoimmune disease (228)
Automation (51)
Bankruptcy (368)
Best Places to Work (11876)
BIOSECURE Act (20)
Biosimilars (209)
Biotechnology (183)
Bladder cancer (177)
Brain cancer (65)
Breast cancer (699)
Cancer (5399)
Cardiovascular disease (464)
Career advice (1807)
Career pathing (42)
CAR-T (308)
CDC (55)
Celiac Disease (2)
Cell therapy (827)
Cervical cancer (41)
Clinical research (71881)
Collaboration (1934)
Company closure (4)
Compensation (1280)
Complete response letters (72)
COVID-19 (2803)
CRISPR (103)
C-suite (1000)
Cystic fibrosis (149)
Data (7118)
Decentralized trials (3)
Denatured (30)
Depression (154)
Dermatology (57)
Diabetes (567)
Diagnostics (7066)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (306)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (267)
Earnings (93100)
Editorial (62)
Employer branding (21)
Employer resources (155)
Events (121916)
Executive appointments (1053)
FDA (20390)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1642)
Gene editing (220)
Generative AI (54)
Gene therapy (673)
GLP-1 (1071)
Government (4846)
Grass and pollen (7)
Guidances (397)
Healthcare (19430)
HIV (76)
Huntington's disease (52)
IgA nephropathy (92)
Immunology and inflammation (278)
Immuno-oncology (83)
Indications (157)
Infectious disease (3119)
Inflammatory bowel disease (208)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (278)
Interviews (329)
IPO (16913)
IRA (50)
Job creations (3777)
Job search strategy (1511)
JPM (58)
Kidney cancer (19)
Labor market (93)
Layoffs (571)
Leadership (37)
Legal (8182)
Liver cancer (100)
Longevity (28)
Lung cancer (730)
Lymphoma (413)
Machine learning (52)
Management (61)
Manufacturing (937)
MASH (178)
Medical device (14237)
Medtech (14316)
Mergers & acquisitions (20490)
Metabolic disorders (1452)
mRNA (181)
Multiple sclerosis (174)
NASH (18)
Neurodegenerative disease (397)
Neuropsychiatric disorders (98)
Neuroscience (3206)
Neurotech (1)
NextGen: Class of 2026 (6722)
Non-profit (4682)
Now hiring (73)
Obesity (689)
Opinion (291)
Ovarian cancer (186)
Pain (229)
Pancreatic cancer (259)
Parkinson's disease (348)
Partnered (34)
Patents (560)
Patient recruitment (595)
Peanut (60)
People (60850)
Pharmaceutical (64)
Pharmacy benefit managers (32)
Phase 1 (22416)
Phase 2 (31548)
Phase 3 (23546)
Pipeline (7161)
Policy (307)
Postmarket research (2756)
Preclinical (9587)
Press Release (69)
Prostate cancer (278)
Psychedelics (51)
Radiopharmaceuticals (309)
Rare diseases (1016)
Real estate (6138)
Recruiting (71)
Regulatory (25688)
Reports (54)
Research institute (2535)
Resumes & cover letters (362)
Rett syndrome (32)
RNA editing (18)
RSV (85)
Schizophrenia (166)
Series A (273)
Series B (202)
Service/supplier (12)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (46)
Startups (3741)
State (2)
Stomach cancer (18)
Supply chain (119)
Tariffs (87)
The Weekly (62)
Vaccines (1087)
Venture capital (101)
Weight loss (449)
Women's health (111)
Worklife (20)
Date
Last 7 days (647)
Last 30 days (2457)
Last 365 days (30372)
2026 (8104)
2025 (30695)
2024 (35788)
2023 (40793)
2022 (51985)
2021 (56595)
2020 (55111)
2019 (47899)
2018 (36108)
2017 (33246)
2016 (32887)
2015 (38940)
2014 (32681)
2013 (27823)
2012 (30059)
2011 (30643)
2010 (28817)
Location
Africa (804)
Alabama (90)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (41762)
Australia (6956)
California (12370)
Canada (3523)
China (1259)
Colorado (524)
Connecticut (524)
Delaware (367)
Europe (92149)
Florida (1856)
Georgia (397)
Hawaii (3)
Idaho (63)
Illinois (973)
India (83)
Indiana (564)
Iowa (22)
Japan (493)
Kansas (131)
Kentucky (44)
Louisiana (39)
Maine (85)
Maryland (1498)
Massachusetts (8902)
Michigan (357)
Minnesota (686)
Mississippi (6)
Missouri (147)
Montana (34)
Nebraska (29)
Nevada (135)
New Hampshire (83)
New Jersey (3287)
New Mexico (29)
New York (3266)
North Carolina (1602)
North Dakota (9)
Northern California (6108)
Ohio (370)
Oklahoma (23)
Oregon (43)
Pennsylvania (2488)
Puerto Rico (26)
Rhode Island (50)
South America (1189)
South Carolina (76)
South Dakota (1)
Southern California (4857)
Tennessee (200)
Texas (1949)
United States (43926)
Utah (373)
Vermont (1)
Virginia (292)
Washington D.C. (82)
Washington State (984)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
751,578 Results for "synthetic blood international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout
While tonlamarsen missed one of two co-primary endpoints, Kardigan says the drug has shown a clinically meaningful effect on blood pressure, supporting advancement into Phase 2b.
March 30, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
/C O R R E C T I O N -- BLOOD CANCER UNITED, INC./
February 17, 2026
·
3 min read
Weight loss
Novo’s Next-Gen Obesity Drug Beats Wegovy on Blood Sugar Control in Phase III
While CagriSema bested Novo Nordisk’s Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma’s 25% weight loss goal.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid CDx
March 10, 2026
·
6 min read
Press Releases
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
March 19, 2026
·
3 min read
Press Releases
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G Nfl Blood Assay
March 17, 2026
·
2 min read
Press Releases
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026
·
2 min read
Press Releases
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
March 9, 2026
·
5 min read
Press Releases
Trividia Health, Inc. Initiates Voluntary Recall of Limited Number of TRUE METRIX® Blood Glucose Meters
October 7, 2025
·
2 min read
Press Releases
FDA Grants Breakthrough Device Designation to MeMed BV Flex™ Capillary Blood
March 11, 2026
·
3 min read
1 of 75,158
Next
